Net profit of Bal Pharma declined 46.07% to Rs 0.48 crore in the quarter ended December 2024 as against Rs 0.89 crore during the previous quarter ended December 2023. Sales declined 10.42% to Rs 73.15 crore in the quarter ended December 2024 as against Rs 81.66 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 73.15 | 81.66 | -10 |
| OPM % | 10.59 | 9.54 | - |
| PBDT | 3.25 | 4.23 | -23 |
| PBT | 0.57 | 1.27 | -55 |
| NP | 0.48 | 0.89 | -46 |